Strategies to minimize weight gain after smoking cessation: Psycological and pharmacological intervention with specific reference to dexfenfluramine

B. Spring*, R. Pingitore, K. Kessler

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Cigarette smoking suppresses body weight, discouraging many smokers from trying to quit. Behavioural therapies have so far proved unsuccessful in preventing post-cessation weight gain, and have in fact tended to undercut abstinence from smoking. The mental demands of implementing behavioural weight management strategies may compete with the concentration needed to maintain abstinence from smoking. Consequently, a pharmacological approach offers potential treatment advantages by minimizing the effort needed to achieve weight control. Of the agents found effective in minimizing weight gain, serotoninergic drugs, particularly dexfenfluramine, show special promise because they prevent an increase in caloric intake but do not decrease energy intake below pre-cessation levels.

Original languageEnglish (US)
JournalInternational Journal of Obesity
Volume16
Issue numberSUPPL. 3
StatePublished - Dec 1 1992

Keywords

  • Body weight
  • Carbohydrate
  • Cigarette smoking
  • Dexfenfluramine
  • Serotonin

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Fingerprint

Dive into the research topics of 'Strategies to minimize weight gain after smoking cessation: Psycological and pharmacological intervention with specific reference to dexfenfluramine'. Together they form a unique fingerprint.

Cite this